1. Mvasi is a biosimilar version of Roche’s cancer drug Avastin.
2. Aliqopa is intended to treat adults with relapsed follicular lymphoma who have received at least two previous therapies for the disease.
3. Mylotarg may now be used to treat adults with newly diagnosed acute myeloid leukemia, along with patients two years and older who have experienced a relapse or have not responded to previous treatments.
4. Doxycycline hyclate tablets, a generic version of Pfizer’s Vibra-Tabs, are intended to treat various bacterial infections.
5. Reset is the first mobile app used to aid in the treatment of individuals with substance use disorders.
More articles on supply chain:
Teva to sell contraceptive device business for $1.1B, divest remaining women’s health assets
6 must-reads for supply chain leaders
Supply chain inefficiencies leave $23B in potential savings on the table for hospitals
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
